Dr. Tyrone C. Malloy: Research and Studies
Abnormal Pap A Randomized, Single Blind, Placebo Controlled Phase 2 Study to assess the Safety of ADXS XXXX for the Treatment of Cervical Intraepithelial Neoplasia Grade 2/3
Principal Investigator
Sponsor: Advaxis
A randomized, double blind, placebo controlled, parallel group, multicenter study of the safety and response rate of 3 subcutaneously administered doses of X in patient with high grade cervical intraepithelial neoplasia grade 2 or 3 associated with High Risk HPV infection
Principal Investigator
Sponsor: Roche
Randomized, Placebo-Controlled Phase 2 Study of Multiple Dosing Regimens of Intravaginally Administered X Gel for the Treatment of Cervical High Risk HPV Infection
Principal Investigator
Sponsor: Takeda Global Research
A Multi-Center Prospective Clinical Study to Evaluate the Performance and Clinical Predictive Value of the Invaderâ HPV HR Molecular Assay and Invaderâ HPV 16/18 Molecular Assay for the Detection of Human Papilloma Virus in Cervical Cytology Samples
Principal Investigator
Sponsor: Third Wave Technologies
Abortion/Family
Planning Acceptability and Feasibility of
Early Pregnancy Termination by
Mifepristone-Misoprostol.
Principal Investigator
Low Dose Mifepristone Plus Vaginal
Misoprostol for Abortion up to 63
Days Gestation.
Principal Investigator
A Copy Mifepristone Product Plus Misoprostol for Medical Induction
of Early Abortion: Low Dose
Mifepristone Trial.
Principal Investigator
